Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition
Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition
复制标题
前列腺素 E2 通过 EP2/EP4 受体抑制人羊膜成纤维细胞中的赖氨酰氧化酶:对分娩的影响
DOI:
10.1016/j.mce.2016.01.022
复制
发表时间:
2016-03
影响因子:
4.1
通讯作者:
Sun Kang
中科院分区:
文献类型:
--
作者:
Liu Chao;Zhu Ping;Wang Wangsheng;Li Wenjiao;Shu Qun;Chen Zi-Jiang;Myatt Leslie;Sun Kang
The underlying mechanism leading to rupture of the membranes at parturition is not fully understood. Lysyl oxidase (LOX) cross-links collagen fibrils thereby increasing the tensile strength of the membranes. Thus, understanding the regulation of LOX expression may be of crucial importance for elucidation of the process of rupture of the fetal membranes. Prostaglandin E2 (PGE2), mainly produced in the amnion, plays crucial roles during human parturition. However it is not known whether PGE2 regulates LOX expression in the fetal membranes. Using primary human amnion fibroblasts, we showed that addition of PGE2 decreased LOX mRNA and protein levels, which were blocked by inhibition of EP2/EP4 receptors and the receptor-coupled cAMP/PKA pathway. EP2/EP4 receptor agonists and stimulators of the cAMP/PKA pathway consistently decreased LOX expression. Furthermore, PGE2 induced cyclo-oxygenase-2 (COX-2) expression, a key enzyme in PGE2 production, via an EP2 and EP4 receptor-coupled cAMP/PKA pathway. Small interfering RNA-mediated knock-down of COX-2 expression significantly increased the basal expression of LOX. In addition, an increase in COX-2 and a reciprocal decrease in LOX abundance occurred in amnion tissue following labor at term. In conclusion, we have revealed a feed-forward loop of induction of COX-2 and reduction in LOX expression by PGE2 acting via an EP2/EP4 receptor-coupled cAMP/PKA pathway in human amnion fibroblasts toward the end of gestation, which may play a significant role in the rupture of fetal membranes.
登录
查看更多内容
影响因子:
4.8
作者:
Faour, Wissam H.;Gomi, Kaede;Kennedy, Christopher R. J.
通讯作者:
Kennedy, Christopher R. J.
DOI:
10.1016/s0090-6980(75)80113-4
发表时间:
1975
期刊:
Prostaglandins
影响因子:
--
作者:
W. L. Miller;J. Weeks;J. Lauderdale;K. Kirton
通讯作者:
W. L. Miller;J. Weeks;J. Lauderdale;K. Kirton
影响因子:
3.6
作者:
J. Regan;T. Bailey;D. J. Pepperl;K. L. Pierce;A. Bogardus;J. Donello;C. E. Fairbairn;K. Kedzie;D. Woodward;D. Gil
通讯作者:
J. Regan;T. Bailey;D. J. Pepperl;K. L. Pierce;A. Bogardus;J. Donello;C. E. Fairbairn;K. Kedzie;D. Woodward;D. Gil
DOI:
10.1210/jcem.87.3.8320
发表时间:
2002-03
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
P. Xu;N. Alfaidy;J. Challis
通讯作者:
P. Xu;N. Alfaidy;J. Challis
DOI:
10.1172/jci37785
发表时间:
2008-12
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Michael J. Taggart;G. Nicholas Europe-Finner;Bryan F. Mitchell
通讯作者:
Michael J. Taggart;G. Nicholas Europe-Finner;Bryan F. Mitchell